United OrthopedicROCO:4129 -2.64%81 EBITDA Margin % is 21.81% as of Dec. 2025, which is 16% above its 10-year median of 18.81. GuruFocus rates ROCO:4129 with a GF Score™ of 81/100 and a GF Value™ of NT$123.47 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, United Orthopedic ranks better than 82.72% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. United Orthopedic's EBITDA for the
three
months ended in Dec. 2025 was NT$331 Mil. United Orthopedic's Revenue for the
three
months ended in Dec. 2025 was NT$1,516 Mil. Therefore, United Orthopedic's EBITDA margin for the quarter that ended in Dec. 2025 was 21.81%.
United Orthopedic (ROCO:4129) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
United Orthopedic EBITDA Margin % Related Terms
United Orthopedic EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for United Orthopedic's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4129 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, United Orthopedic's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
United Orthopedic EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, United Orthopedic's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where United Orthopedic's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Orthopedic (ROCO:4129) has a EBITDA Margin % of 21.81% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on United Orthopedic and its competitors. This is 16% above median its historical median of 18.81. Over the past decade, United Orthopedic's EBITDA Margin % has ranged from 14.97 to 24.17. According to the industry distribution chart, United Orthopedic ranks #141 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 17.3%.
Is United Orthopedic's EBITDA Margin % too high?
United Orthopedic's current EBITDA Margin % of 21.81% is 16% above median its 10-year median of 18.81. Over the past 10 years, this metric has ranged from a low of 14.97 to a high of 24.17. The Medical Devices & Instruments industry median EBITDA Margin % is 7.39. United Orthopedic's value of 21.81% is 195.3% above this industry median. Based on the distribution chart, United Orthopedic ranks #141 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, United Orthopedic has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does United Orthopedic's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, United Orthopedic ranks #141 out of 816 companies for EBITDA Margin %. This places United Orthopedic in the top 17% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.39. United Orthopedic's value of 21.81% is 195.3% above this benchmark. Historically, United Orthopedic's own EBITDA Margin % has ranged from 14.97 to 24.17 over the past decade. While the company's 10-year median is 18.81 vs. the industry median of 7.39, United Orthopedic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.39, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. United Orthopedic's current EBITDA Margin % of 21.81% is 195.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on United Orthopedic and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. United Orthopedic's current EBITDA Margin % is 21.81%, which is 16% above median its own 10-year median of 18.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Orthopedic stock overvalued right now?
Based on GuruFocus' analysis, United Orthopedic (ROCO:4129) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$123.47, compared to a current price of NT$88.50 — trading 28.3% below its estimated fair value. The current EBITDA Margin % is 21.81%, which is 16% above median its 10-year median of 18.81 and 195.3% above the Medical Devices & Instruments industry median of 7.39. United Orthopedic's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For United Orthopedic (ROCO:4129), the current EBITDA Margin % is 21.81% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is United Orthopedic (ROCO:4129) Overvalued in 2026?
Based on GuruFocus' analysis, United Orthopedic stock appears to be undervalued.
The current stock price of NT$88.50 is trading 28.3% below its estimated GF Value™ of NT$123.47.
GuruFocus considers United Orthopedic to be Modestly Undervalued.
Key valuation signals for ROCO:4129:
EBITDA Margin %: 21.81% (16% above median its 10-year median of 18.81)
GF Value™: NT$123.47 vs. price of NT$88.50 (28.3% below fair value)
Industry Position: 195.3% above the Medical Devices & Instruments median (#141 of 816)
No single metric tells the full story. See the ROCO:4129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
United Orthopedic Corp is engaged in the research, development, production, manufacturing, and sales of orthopedic implants, orthopedic surgical instruments and manufacturing equipment, special metal and plastics materials, as well as the import and export of the aforementioned products. Its products include Hip System, Knee System, and Limb Salvage.
81GF Score
Get the complete analysis for ROCO:4129
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4129 has been successfully added to your 
